The goal of the present set of studies was to characterize the in vitro binding properties and in vivo tissue kinetics for the vesicular acetylcholine transporter (VAcChT) radiotracer, [ 18 F](1)-4-fluorobenzyltrozamicol ([ 18 F](1)-FBT). In vitro binding studies were conducted in order to determine
Neurofunctional imaging of the pancreas utilizing the cholinergic PET radioligand [18F]4-fluorobenzyltrozamicol
✍ Scribed by P.B. Clark; H.D. Gage; C. Brown-Proctor; N. Buchheimer; J. Calles-Escandon; R.H. Mach; K.A. Morton
- Book ID
- 105962047
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 215 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Recently, a novel series of 2‐phenylpyrazolo[1,5‐__a__]pyrimidineacetamides has been reported as selective ligands of the translocator protein (18 kDa). Within this series, DPA‐714 (__N,N__‐diethyl‐2‐(2‐(4‐(2‐fluoroethoxy)phenyl)‐5,7‐dimethylpyrazolo[1,5‐__a__]pyrimidin‐3‐yl)acetamide,
## Abstract PBR111 (2‐(6‐chloro‐2‐(4‐(3‐fluoropropoxy)phenyl)imidazo[1,2‐__a__]pyridin‐3‐yl)‐__N__,__N__‐diethylacetamide) is a novel, reported, high‐affinity and selective ligand for the translocator protein (18 kDa). PBR111 has been labelled with fluorine‐18 (half‐life: 109.8 min) using our Zymat